Get your full text copy in PDF
Junfei Zhao, Hongyuan Wang, Weizhen Hu, Yuanhong Jin
(Respiratory Department, The Sixth Affiliated Hospital of Wenzhou Medical University, People’s Hospital, Lishui, China (mainland))
Med Sci Monit 2014; 20:2461-2465
DOI: 10.12659/MSM.891141
Background:
The association between the HLA-B-associated transcript 3 polymorphisms and lung cancer risk is a subject of debate. We conducted a meta-analysis to evaluate the association between these polymorphisms and lung cancer susceptibility.
Material and Methods:
A systematic search of electronic databases (PubMed, EMBASE, Wanfang, and China National Knowledge Infrastructure) was performed. Data were extracted and pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated.
Results:
Ten case-control studies with 37 945 and 56 807 controls were included in this meta-analysis. Overall, a significant association between rs1052486 polymorphism and lung cancer susceptibility was observed (OR=1.07, 95% CI 1.01–1.12, P=0.01). In addition, a significant association was found for rs3117582 polymorphism (OR=1.29, 95% CI 1.22–1.37, P<0.01).
Conclusions:
This meta-analysis suggested that HLA-B-associated transcript 3 polymorphisms are risk factors for lung cancer.